244 related articles for article (PubMed ID: 36717944)
1. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
2. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
3. ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Wang R; Gao D; Chen C; Fan G; Cheng H; Tao Y; Lu J; Tian J; Wang Y; Wang Z
Clin Transl Oncol; 2023 May; 25(5):1425-1435. PubMed ID: 36512304
[TBL] [Abstract][Full Text] [Related]
4. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
5. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
[TBL] [Abstract][Full Text] [Related]
6. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
[TBL] [Abstract][Full Text] [Related]
7. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
8. NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway.
Guo J; Ke S; Chen Q; Zhou J; Guo J; Qiu T
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511343
[TBL] [Abstract][Full Text] [Related]
9. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
Wang Q; Liao C; Tan Z; Li X; Guan X; Li H; Tian Z; Liu J; An J
Cancer Gene Ther; 2023 Jan; 30(1):182-191. PubMed ID: 36151332
[TBL] [Abstract][Full Text] [Related]
10. MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration.
Zhu J; Cui L; Xu A; Yin X; Li F; Gao J
BMC Cancer; 2017 Mar; 17(1):176. PubMed ID: 28270206
[TBL] [Abstract][Full Text] [Related]
11. RIN1 promotes renal cell carcinoma malignancy by activating EGFR signaling through Rab25.
Feng ZH; Fang Y; Zhao LY; Lu J; Wang YQ; Chen ZH; Huang Y; Wei JH; Liang YP; Cen JJ; Pan YH; Liao B; Chen W; Luo JH
Cancer Sci; 2017 Aug; 108(8):1620-1627. PubMed ID: 28612496
[TBL] [Abstract][Full Text] [Related]
12. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
14. LIMD2 promotes tumor proliferation, invasion, and epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Zhong QY; Xie YW; Chen ZL; Chen YQ; Liu YX; Xie WL; Yan W
Neoplasma; 2022 Jul; 69(4):832-840. PubMed ID: 35532296
[TBL] [Abstract][Full Text] [Related]
15. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
16. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
[TBL] [Abstract][Full Text] [Related]
18. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
[TBL] [Abstract][Full Text] [Related]
19. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
20. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
